PTC THERAPEUTICS INC - NOTE 1.500% 9/1

Historical Holders from Q2 2022 to Q4 2025

Type / Class
Debt / NOTE 1.500% 9/1
Market price (% of par)
148.19%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal as of 30 Sep 2025
$278,232,000
Total reported market value
$296,027,478
Principal change
+$2,849,000
Market value change
+$725,502
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
16 filings reported holding 69366JAD3 - PTC THERAPEUTICS INC - NOTE 1.500% 9/1.
PTC THERAPEUTICS INC - NOTE 1.500% 9/1 has 15 institutional bondholders. These institutions hold $278,232,000 principal (par value) of the bond.

Institutional Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2025 Q4 $227,000 $336,391 -$87,432 148.19% 1
2025 Q3 $278,232,000 $296,027,478 +$725,502 128.25% 15
2025 Q2 $275,383,000 $318,055,093 -$3,252,102 115.48% 15
2025 Q1 $276,612,000 $326,799,984 +$764,592 117.03% 14
2024 Q4 $264,421,591 $309,275,303 -$20,168,580 111.67% 13
2024 Q3 $259,449,591 $309,774,451 +$582,114 103.98% 12
2024 Q2 $259,449,591 $284,800,544 +$182,994 95.4% 12
2024 Q1 $274,717,308 $277,129,832 -$20,916,765,749 93.25% 14
2023 Q4 $287,509,503 $273,105,852 +$15,160,001 91.88% 14
2023 Q3 $278,652,272 $229,332,855 -$3,058,195 79.7% 20
2023 Q2 $287,637,000 $296,005,222 -$2,491,781 102.75% 19
2023 Q1 $279,704,527 $327,735,385 +$7,856,990 113.7% 17
2022 Q4 $287,400,000 $284,218,480 -$1,258,207 98.54% 10
2022 Q3 $287,600,000 $336,226,000 +$32,736,045 117.21% 11
2022 Q2 $262,509,000 $275,443,000 +$275,443,000 104.71% 10